Neuronetics Announces Strategic Leadership Promotions to Support Future Growth
11 févr. 2021 08h00 HE
|
Neuronetics
MALVERN, Pa., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NeuroStar® Advanced Therapy’s Depression Outcomes Registry Hits 10,000 Patient Milestone
19 janv. 2021 08h00 HE
|
Neuronetics
MALVERN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners
08 déc. 2020 16h05 HE
|
Neuronetics
MALVERN, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol
23 nov. 2020 16h05 HE
|
Neuronetics
MALVERN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
02 nov. 2020 16h05 HE
|
Neuronetics
MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Journal of Affective Disorders Publishes Clinical Data Suggesting NeuroStar® Advanced Therapy as a First-line Treatment for Major Depressive Disorder
13 oct. 2020 08h00 HE
|
Neuronetics
MALVERN, Pa., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month
01 oct. 2020 08h00 HE
|
Neuronetics
MALVERN, Pa., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS
29 sept. 2020 08h00 HE
|
Neuronetics
MALVERN, Pa., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Unveils New Depression Data at Clinical TMS Society’s Virtual Events
22 sept. 2020 08h00 HE
|
Neuronetics
MALVERN, Pa., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Second Quarter 2020 Financial and Operating Results
04 août 2020 07h30 HE
|
Neuronetics
MALVERN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...